[ 7 ] Dellis A, Joshi HB, Timoney AG, et al. Relief of stent related symptoms: review of engineering and pharmacological solutions[J]. J Urol, 2010, 184(4): 1267-1272.
[8]
[ 8 ] Damiano R, Oliva A, Esposito C, et al. Early and late complications of double pigtail ureteral stent[J]. Urol Int, 2002, 69(2): 136-140.
[9]
[ 9 ] Gr？n PL. Papillary transitional cell carcinoma of the bladder after 1 year use of a double-J ureteral catheter[J]. Ugeskr Laeger, 1993, 155(34): 2628-2629.
[10]
Hola V, Peroutkova T, Ruzicka F. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections[J]. FEMS Immunol Med Microbiol, 2012, 65(2): 343-349.
[11]
Lojanapiwat B, Kitirattrakarn P. Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy[J]. Urol Int, 2011, 86(4): 448-452.
[12]
Sharifi Aghdas F, Akhavizadegan H, Aryanpoor A, et al. Fever after percutaneous nephrolithotomy: contributing factors[J]. Surg Infect (Larchmt), 2006, 7(4): 367-371.
[13]
Wang Y, Jiang F, Wang Y, et al. Post-percutaneous nephrolithotomy septic shock and severe hemorrhage: a study of risk factors[J]. Urol Int, 2012, 88(3): 307-310.
[14]
Rana AM, Mithani S. Tubeless percutaneous nephrolithotomy: call of the day[J]. J Endourol, 2007, 21(2): 169-172.
Sakamoto Y, Mashiko K, Matsumoto H, et al. Selection of acute blood purification therapy according to severity score and blood lactic acid value in patients with septic shock[J]. Indian J Crit Care Med, 2010, 14(4): 175-179.
[17]
Vignali C, Lonzi S, Bargellini I, et al. Vascular injuries after percutaneous renal procedures: treatment by transcatheter embolization[J]. Eur Radiol, 2004, 14(4): 723-729.
[18]
Keoghane SR, Cetti RJ, Rogers AE, et al. Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL)[J]. BJU Int, 2013, 111(4): 628-632.
[19]
Ogan K, Corwin TS, Smith T, et al. Sensitivity of chest fluoroscopy compared with chest CT and chest radiography for diagnosing hydropneumothorax in association with percutaneous nephrostolithotomy[J]. Urology, 2003, 62(6): 988-992.
[20]
Liumbruno GM, Franchini M. Proteomic analysis of venous thromboembolism: an update[J]. Expert Rev Proteomics, 2013, 10(2): 179-188.
[21]
Ljunghall S, Danielson BG. A prospective study of renal stone recurrences[J]. Br J Urol, 1984, 56(2): 122-124.
[22]
Holmes RP, Assimos DG. The impact of dietary oxalate on kidney stone formation[J]. Urol Res, 2004, 32(5): 311-316.
[23]
Hiatt RA, Ettinger B, Caan B, et al. Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones[J]. Am J Epidemiol, 1996, 144(1): 25-33.
[24]
Siener R, Petzold J, Bitterlich N, et al. Determinants of urolithiasis in patients with intestinal fat malabsorption[J]. Urology, 2013, 81(1): 17-24.
Fjellstedt E, Denneberg T, Jeppsson JO, et al. A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria[J]. Urol Res, 2001, 29(5): 295-302.
[27]
Rinnab L, Hautmann RE, Straub M. Alkaline citrates in urology. A status report[J]. Urologe A, 2004, 43(4): 429-439.
